(Q37760097)

22 August 2017

1 reference

title

Recent concepts of antiangiogenic therapy (English)

1 reference

22 August 2017

main subject

angiogenesis inhibitor

1 reference

Hiroyuki Konno

1

1 reference

22 August 2017

Masayoshi Yamamoto

series ordinal

2

1 reference

22 August 2017

Manabu Ohta

series ordinal

3

1 reference

22 August 2017

publication date

23 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

40

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

494-500

1 reference

Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm.

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00595-009-4150-2

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

21 January 2018

1 reference

12 December 2020

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

1 reference

12 December 2020

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

12 December 2020

Circulating endothelial cells as a novel marker of angiogenesis

1 reference

12 December 2020

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

1 reference

12 December 2020

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

12 December 2020

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

12 December 2020

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

12 December 2020

Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.

1 reference

12 December 2020

Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.

1 reference

12 December 2020

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Vascular-targeting therapies for treatment of malignant disease.

1 reference

12 December 2020

Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice

1 reference

12 December 2020

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

12 December 2020

TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche

1 reference

12 December 2020

TSU68, an antiangiogenic receptor tyrosine kinase inhibitor, induces tumor vascular normalization in a human cancer xenograft nude mouse model

1 reference

12 December 2020

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

1 reference

12 December 2020

VEGF-targeted therapy: mechanisms of anti-tumour activity.

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Disrupting tumour blood vessels

1 reference

12 December 2020

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis

1 reference

12 December 2020

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

12 December 2020

Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model

1 reference

12 December 2020

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

1 reference

12 December 2020

Combination treatment improves breast-cancer survival

1 reference

12 December 2020

Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.

1 reference

12 December 2020

Perioperative host-tumor inflammatory interactions: a potential trigger for disease recurrence following a curative resection for colorectal cancer

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma

1 reference

12 December 2020

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

1 reference

12 December 2020

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

12 December 2020

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

1 reference

12 December 2020

10.1007/S00595-009-4150-2

Identifiers

DOI

1 reference

22 August 2017

1 reference